Very commonly used drugs for prostate cancer–Eligard, Lupron, Synarel, Trelstar, Vantas, Viadur, Zoladex, as well as several generic products, will be required by the FDA to carry warning labels because researchers have linked them to an increased risk of heart disease and diabetes. HealthDay quotes Dr. Nelson Neal Stone, a clinical professor of urology and radiation oncology at Mount Sinai School of Medicine in New York City, reporting that the drugs, which lower the testosterone level, can double the risk of developing metabolic syndrome, a cluster of symptoms tied to the development of heart disease.
Health, fitness and lifestyle tips for people over 50 who still like to play hard
Sunday, June 1, 2025
Many years ago, in the Urological review, I read and article from Dr. Young at the end of his practice as Urologist. I don’t forget his word: a man at the end of his life when diagnosed of prostate cancer, the most at least common activities of Playing golf, have some drink, and some sex; we the Urologist limit that situation with the Radical Surgery, Castration, Antiandrogens, and the most aggresive Radiation Theraphy, and conclude that let them live with his condition and act according to development of symtoms, being consequenttly.
FDA has approved many drugs for different problems, then they are put in some type of trial and find they work for something else, but when they are used for that up comes a heart attack who are we supposed to believe?
A clinical professor of urology and radiation oncology at Mount Sinai School of Medicine in New York City, reporting that the drugs, which lower the testosterone level. These all are good to know about it.